Schmiegelow K - Search Results

1

Can Machine Learning Models Predict Asparaginase-associated Pancreatitis in Childhood Acute Lymphoblastic Leukemia.

Nielsen RL, Wolthers BO, Helenius M, Albertsen BK, Clemmensen L, Nielsen K, Kanerva J, Niinimäki R, Frandsen TL, Attarbaschi A, Barzilai S, Colombini A, Escherich G, Aytan-Aktug D, Liu HC, Möricke A, Samarasinghe S, van der Sluis IM, Stanulla M, Tulstrup M, Yadav R, Zapotocka E, Schmiegelow K, Gupta R. Nielsen RL, et al. Among authors: schmiegelow k. J Pediatr Hematol Oncol. 2022 Apr 1;44(3):e628-e636. doi: 10.1097/MPH.0000000000002292. J Pediatr Hematol Oncol. 2022. PMID: 35226426 Free PMC article.

2

Prognostic significance of methotrexate and 6-mercaptopurine dosage during maintenance chemotherapy for childhood acute lymphoblastic leukemia.

Schmiegelow K. Schmiegelow K. Pediatr Hematol Oncol. 1991 Oct-Dec;8(4):301-12. doi: 10.3109/08880019109028803. Pediatr Hematol Oncol. 1991. PMID: 1782110

3

Maintenance chemotherapy for childhood acute lymphoblastic leukemia: should dosage be guided by white blood cell counts?

Schmiegelow K, Pulczynska MK. Schmiegelow K, et al. Am J Pediatr Hematol Oncol. 1990 Winter;12(4):462-7. doi: 10.1097/00043426-199024000-00010. Am J Pediatr Hematol Oncol. 1990. PMID: 2285127

4

White-cell counts in childhood acute lymphoblastic leukemia.

Schmiegelow K, Pulczynska MK. Schmiegelow K, et al. Eur J Haematol. 1990 Jan;44(1):72-4. doi: 10.1111/j.1600-0609.1990.tb00351.x. Eur J Haematol. 1990. PMID: 2307222 No abstract available.

5

6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and its relation to leukopenia.

Schmiegelow K, Bruunshuus I. Schmiegelow K, et al. Cancer Chemother Pharmacol. 1990;26(4):288-92. doi: 10.1007/BF02897232. Cancer Chemother Pharmacol. 1990. PMID: 2369793

6

Maintenance chemotherapy for childhood acute lymphoblastic leukemia: relation of bone-marrow and hepatotoxicity to the concentration of methotrexate in erythrocytes.

Schmiegelow K, Schrøder H, Pulczynska MK, Hejl M. Schmiegelow K, et al. Cancer Chemother Pharmacol. 1989;25(1):65-9. doi: 10.1007/BF00694341. Cancer Chemother Pharmacol. 1989. PMID: 2591003

7

White cell count during maintenance chemotherapy for standard-risk childhood acute lymphoblastic leukemia: relation to relapse rate.

Schmiegelow K, Pulczynska MK, Seip M. Schmiegelow K, et al. Pediatr Hematol Oncol. 1988;5(4):259-67. doi: 10.3109/08880018809037365. Pediatr Hematol Oncol. 1988. PMID: 3152971

8

Methotrexate and 6-mercaptopurine maintenance therapy for childhood acute lymphoblastic leukemia: dose adjustments by white cell counts or by pharmacokinetic parameters?

Schmiegelow K, Schrøder H, Schmiegelow M. Schmiegelow K, et al. Among authors: schmiegelow m. Cancer Chemother Pharmacol. 1994;34(3):209-15. doi: 10.1007/BF00685079. Cancer Chemother Pharmacol. 1994. PMID: 8004753

9

Varicella zoster infections in children with acute lymphoblastic leukemia.

Poulsen A, Schmiegelow K, Yssing M. Poulsen A, et al. Among authors: schmiegelow k. Pediatr Hematol Oncol. 1996 May-Jun;13(3):231-8. doi: 10.3109/08880019609030821. Pediatr Hematol Oncol. 1996. PMID: 8735338

10

Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia. Nordic Society for Pediatric Hematology and Oncology (NOPHO).

Schmiegelow K, Glomstein A, Kristinsson J, Salmi T, Schrøder H, Björk O. Schmiegelow K, et al. J Pediatr Hematol Oncol. 1997 Mar-Apr;19(2):102-9. doi: 10.1097/00043426-199703000-00002. J Pediatr Hematol Oncol. 1997. PMID: 9149738

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

556 results

Search Page

Filters